{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:21:24Z","timestamp":1779294084675,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,30]]},"DOI":"10.7759\/cureus.34395","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T18:17:53Z","timestamp":1675102673000},"source":"Crossref","is-referenced-by-count":3,"title":["Maternal and Fetal Outcome in Pregnant Women With Critical COVID-19 Treated With Tocilizumab in a Tertiary Care Hospital in Dubai"],"prefix":"10.7759","author":[{"given":"Bindu","family":"Isaac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Komal","family":"Hazari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deemah K","family":"Harb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaz K","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Widad","family":"Abdelkareem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeir","family":"Ammar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taghrid","family":"Gergawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiman","family":"Saeed Al Zahmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar H","family":"Khamis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"WHO coronavirus (COVID-19) dashboard. (2023). https.\/\/covid19.who.int\/."},{"key":"ref2","unstructured":"WHO coronavirus (COVID-19) dashboard. United Arab Emirates. (2023). https:\/\/covid19.who.int\/region\/emro\/country\/ae."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6944e3","article-title":"Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-October 3, 2020","volume":"69","author":"Zambrano LD","year":"2020","unstructured":"Zambrano LD, Ellington S, Strid P, et al.. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020, 69:1641-7. 10.15585\/mmwr.mm6944e3","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.12.1221","article-title":"Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington State","volume":"225","author":"Lokken EM","year":"2021","unstructured":"Lokken EM, Huebner EM, Taylor GG, et al.. Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington State. Am J Obstet Gynecol. 2021, 225:1-14. 10.1016\/j.ajog.2020.12.1221","journal-title":"Am J Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-020-00146-3","article-title":"How COVID-19 induces cytokine storm with high mortality","volume":"40","author":"Hojyo S","year":"2020","unstructured":"Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, Hirano T. How COVID-19 induces cytokine storm with high mortality. Inflamm Regen. 2020, 40:10.1186\/s41232-020-00146-3","journal-title":"Inflamm Regen"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2108482","article-title":"Interleukin-6 receptor antagonists in critically Ill patients with COVID-19","volume":"385","author":"Brown MJ","year":"2021","unstructured":"Brown MJ, Alazawi W, Kanoni S. Interleukin-6 receptor antagonists in critically Ill patients with COVID-19. N Engl J Med. 2021, 385:10.1056\/NEJMc2108482","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.08.016","article-title":"Tocilizumab for coronavirus disease 2019 in pregnancy and lactation: a narrative review","volume":"28","author":"Jorgensen SC","year":"2022","unstructured":"Jorgensen SC, Lapinsky SE. Tocilizumab for coronavirus disease 2019 in pregnancy and lactation: a narrative review. Clin Microbiol Infect. 2022, 28:51-7. 10.1016\/j.cmi.2021.08.016","journal-title":"Clin Microbiol Infect"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X14551568","article-title":"Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to know","volume":"6","author":"Krause ML","year":"2014","unstructured":"Krause ML, Amin S, Makol A. Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to know. Ther Adv Musculoskelet Dis. 2014, 6:169-84. 10.1177\/1759720X14551568","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020201754","article-title":"Clinical and chest radiography features determine patient outcomes in young and middle-aged adults with COVID-19","volume":"297","author":"Toussie D","year":"2020","unstructured":"Toussie D, Voutsinas N, Finkelstein M, et al.. Clinical and chest radiography features determine patient outcomes in young and middle-aged adults with COVID-19. Radiology. 2020, 297:197-206. 10.1148\/radiol.2020201754","journal-title":"Radiology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30483-7","article-title":"A minimal common outcome measure set for COVID-19 clinical research","volume":"20","year":"2020","unstructured":"A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020, 20.192-7. 10.1016\/S1473-3099(20)30483-7","journal-title":"Lancet Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan WJ","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, et al.. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020, 382:1708-20. 10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2020-10-3","article-title":"Current treatment in COVID-19 disease: a rapid review","volume":"10","author":"Rodriguez-Guerra M","year":"2021","unstructured":"Rodriguez-Guerra M, Jadhav P, Vittorio TJ. Current treatment in COVID-19 disease: a rapid review. Drugs Context. 2021, 10:10.7573\/dic.2020-10-3","journal-title":"Drugs Context"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu X","year":"2020","unstructured":"Xu X, Han M, Li T, et al.. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A. 2020, 117:10970-5. 10.1073\/pnas.2005615117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy","volume":"19","author":"Toniati P","year":"2020","unstructured":"Toniati P, Piva S, Cattalini M, et al.. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020, 19:10.1016\/j.autrev.2020.102568","journal-title":"Autoimmun Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/uog.22014","article-title":"Coronavirus in pregnancy and delivery: rapid review","volume":"55","author":"Mullins E","year":"2020","unstructured":"Mullins E, Evans D, Viner RM, O'Brien P, Morris E. Coronavirus in pregnancy and delivery: rapid review. Ultrasound Obstet Gynecol. 2020, 55:586-92. 10.1002\/uog.22014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2018.04.005","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection during pregnancy: report of two cases and review of the literature","volume":"52","author":"Alfaraj SH","year":"2019","unstructured":"Alfaraj SH, Al-Tawfiq JA, Memish ZA. Middle East respiratory syndrome coronavirus (MERS-CoV) infection during pregnancy: report of two cases and review of the literature. J Microbiol Immunol Infect. 2019, 52:501-3. 10.1016\/j.jmii.2018.04.005","journal-title":"J Microbiol Immunol Infect"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-021-03010-1","article-title":"Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two\u00a0case reports","volume":"15","author":"Abdullah S","year":"2021","unstructured":"Abdullah S, Bashir N, Mahmood N. Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two\u00a0case reports. J Med Case Rep. 2021, 15:10.1186\/s13256-021-03010-1","journal-title":"J Med Case Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez100","article-title":"Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum","volume":"58","author":"Saito J","year":"2019","unstructured":"Saito J, Yakuwa N, Kaneko K, et al.. Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum. Rheumatology (Oxford). 2019, 58:1505-7. 10.1093\/rheumatology\/kez100","journal-title":"Rheumatology (Oxford)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051247","article-title":"The impact of tocilizumab on radiological changes assessed by quantitative chest CT in severe COVID-19 patients","volume":"11","author":"Anghel AM","year":"2022","unstructured":"Anghel AM, Niculae CM, Manea ED, et al.. The impact of tocilizumab on radiological changes assessed by quantitative chest CT in severe COVID-19 patients. J Clin Med. 2022, 11:10.3390\/jcm11051247","journal-title":"J Clin Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15166","article-title":"Investigation and management of a raised serum ferritin","volume":"181","author":"Cullis JO","year":"2018","unstructured":"Cullis JO, Fitzsimons EJ, Griffiths WJ, Tsochatzis E, Thomas DW. Investigation and management of a raised serum ferritin. Br J Haematol. 2018, 181:331-40. 10.1111\/bjh.15166","journal-title":"Br J Haematol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2007.007167","article-title":"Interpreting indicators of iron status during an acute phase response--lessons from malaria and human immunodeficiency virus","volume":"45","author":"Northrop-Clewes CA","year":"2008","unstructured":"Northrop-Clewes CA. Interpreting indicators of iron status during an acute phase response--lessons from malaria and human immunodeficiency virus. Ann Clin Biochem. 2008, 45:18-32. 10.1258\/acb.2007.007167","journal-title":"Ann Clin Biochem"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI18921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys MB","year":"2003","unstructured":"Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003, 111:1805-12. 10.1172\/JCI18921","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25948","article-title":"Elevated interleukin-6 and severe COVID-19: a meta-analysis","volume":"92","author":"Aziz M","year":"2020","unstructured":"Aziz M, Fatima R, Assaly R. Elevated interleukin-6 and severe COVID-19: a meta-analysis. J Med Virol. 2020, 92:2283-5. 10.1002\/jmv.25948","journal-title":"J Med Virol"},{"key":"ref24","unstructured":"Special considerations in pregnancy. (2022). https.\/\/www.covid19treatmentguidelines.nih.gov\/special-populations\/pregnancy\/."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1721658","article-title":"A review on mode of delivery during COVID-19 between December 2019 and April 2020","volume":"38","author":"Debrabandere ML","year":"2021","unstructured":"Debrabandere ML, Farabaugh DC, Giordano C. A review on mode of delivery during COVID-19 between December 2019 and April 2020. Am J Perinatol. 2021, 38:332-41. 10.1055\/s-0040-1721658","journal-title":"Am J Perinatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/119358-maternal-and-fetal-outcome-in-pregnant-women-with-critical-covid-19-treated-with-tocilizumab-in-a-tertiary-care-hospital-in-dubai","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:50:53Z","timestamp":1707508253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/119358-maternal-and-fetal-outcome-in-pregnant-women-with-critical-covid-19-treated-with-tocilizumab-in-a-tertiary-care-hospital-in-dubai"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.34395","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,30]]}}}